EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY-NC 4.0

Preoperative intensity‐modulated radiation therapy in lower extremity soft tissue sarcomas with and without dose avoidance of uninvolved skin/subcutaneous tissue

Siyer Roohani iD, Anthony M Griffin iD, Zhihui Amy Liu, Charles N Catton, Colleen I Dickie, Peter C Ferguson, David G Kirsch, Brian O'Sullivan, David B Shultz, Kim M Tsoi iD, Philip Wong iD, Jay S Wunder und 1 weitere

Cancer · 2025

DOI: 10.1002/cncr.70049 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Cancer, 2025. Verfasst von Siyer Roohani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Medicine Program, Princess Margaret Cancer Center, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Sarcoma, Radiotherapy, Intensity-Modulated, Lower Extremity, Organ Sparing Treatments. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to evaluate whether dosimetric sparing of uninvolved normal tissues, including skin/subcutaneous flaps , affects acute and late toxicities in preoperative image‐guided intensity‐modulated radiation therapy (IG‐IMRT) for lower extremity soft tissue sarcomas (LE‐STS).

Methods

Patients with LE‐STS from a phase 2 preoperative IG‐IMRT trial (flap‐sparing‐IMRT, 2005–2009) and a prospectively maintained institutional database (standard‐IMRT, 2005–2020) were propensity matched by age, sex, tumor size, grade, location, wound closure, and interval from IG‐IMRT to surgery; all received 50 Gy in 25 fractions preoperatively. The primary outcome was major wound complication (MWC). Secondary outcomes were late Radiation Therapy Oncology Group toxicities, functional scores (Toronto Extremity Salvage Score [TESS]; Musculoskeletal Tumor Society scales [MSTS‐87 or MSTS‐93]), and oncologic outcomes. Kaplan–Meier estimates, cumulative incidence functions, and linear, logistic, and Cox regression were used, as appropriate.

Results

Fifty‐five patients who received flap‐sparing‐IMRT were 1:5 matched to 275 patients who received standard‐IMRT (median follow‐up, 104 vs. 56 months, respectively). Regression analyses identified no significant association between treatment technique and MWCs (29% vs. 27%; odds ratio, 0.92; p = .77), late grade 2 or greater toxicities: subcutaneous fibrosis (15% vs. 8%), joint stiffness (5% vs. 2%), edema (11% vs. 10%), fracture (2% vs. 4%), or functional outcomes (TESS, 87 vs. 89; MSTS‐87, 33 vs. 33; and MSTS‐93, 93 vs. 97; all p > .1). Five‐year overall survival (83.6% vs. 75.2%), disease‐free survival (65.5% vs. 64.1%), local recurrence (5.2% vs. 7.3%), distant metastasis (29.1% vs. 30.1%) were also comparable ( p > .1).

Conclusions

Flap‐sparing‐IMRT with specific avoidance of uninvolved skin/subcutaneous tissues demonstrated minimal differences in MWCs, late toxicity, and functional and oncologic outcomes compared with standard‐IMRT in patients with LE‐STS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaRadiotherapy, Intensity-ModulatedLower ExtremityOrgan Sparing TreatmentsHumansMaleFemaleMiddle AgedAgedAdultSurgical FlapsSkinRadiotherapy DosagePreoperative CareTreatment Outcome

Stichwörter der Autor:innen

IMRTMusculoskeletal Tumor Society scale (MSTS)Toronto Extremity Salvage Score (TESS)flap‐sparingoutcomestoxicitywound complications

Autor:innen und Institutionen

  • Radiation Medicine Program, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Berlin Institute of Health Biomedical Innovation Academy, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • University Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Division of Orthopedic Surgery, Department of Surgery, Sinai Health System, Toronto, Ontario, Canada.
  • Department of Biostatistics, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.

ORCID-Profile: Siyer Roohani, Anthony M Griffin, Kim M Tsoi, Philip Wong

Zitieren

APA

Roohani, S., Griffin, A. M., Liu, Z. A., Catton, C. N., Dickie, C. I., Ferguson, P. C., Kirsch, D. G., O'Sullivan, B., Shultz, D. B., Tsoi, K. M., Wong, P., Wunder, J. S., & Chung, P. W. M. (2025). Preoperative intensity‐modulated radiation therapy in lower extremity soft tissue sarcomas with and without dose avoidance of uninvolved skin/subcutaneous tissue. Cancer. https://doi.org/10.1002/cncr.70049

Vancouver

Roohani S, Griffin AM, Liu ZA, Catton CN, Dickie CI, Ferguson PC, et al. Preoperative intensity‐modulated radiation therapy in lower extremity soft tissue sarcomas with and without dose avoidance of uninvolved skin/subcutaneous tissue. Cancer. 2025. doi:10.1002/cncr.70049

BibTeX
@article{Roohani2025,
  author = {Roohani, Siyer and Griffin, Anthony M and Liu, Zhihui Amy and Catton, Charles N and Dickie, Colleen I and Ferguson, Peter C and Kirsch, David G and O'Sullivan, Brian and Shultz, David B and Tsoi, Kim M and Wong, Philip and Wunder, Jay S and Chung, Peter W M},
  title = {Preoperative intensity‐modulated radiation therapy in lower extremity soft tissue sarcomas with and without dose avoidance of uninvolved skin/subcutaneous tissue},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.70049}
}
Kostenlos starten →